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Abstract  
mHealth is a term used to refer to mobile technologies such as personal digital assistants and mobile phones for healthcare. mHealth initiatives to 
support  care  and  treatment  of  patients  are  emerging  globally  and  this  workshop  brought  together  researchers,  policy  makers,  information, 
communication and technology programmers, academics and civil society representatives for one and a half days synergy meeting in Kenya to 
review  regional  evidence  based  mHealth  research  for  HIV  care  and  treatment,  review  mHealth  technologies  for  adherence  and  retention 
interventions in anti-retroviral therapy (ART) programs and develop a framework for scale up of evidence based mHealth interventions. The 
workshop was held in May 2011 in Nairobi, Kenya and was funded by the Canadian Global Health Research Initiatives (GHRI) and the US Centre 
for Disease Control and Prevention (CDC). At the end of the workshop participants came up with a framework to guide mHealth initiatives in the 
region and a plan to work together in scaling up evidence based mHealth interventions. The participants acknowledged the importance of the 
meeting in setting the pace for strengthening and coordinating mHealth initiatives and unanimously agreed to hold a follow up meeting after three 
months.  
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Introduction 
 
There  have  been  calls  for  more  evidence  on  the  effectiveness  of  mHealth  interventions  to  improve  health  outcomes.  The  WelTel  Kenya1 
intervention evaluating the use of mobile phones to improve adherence to ART is the first randomized controlled trial to show the effectiveness of 
using mobile phones for viral suppression [1]. With these findings in place and with the ever-increasing mHealth interventions being developed, a 
coordinated approach among various players is essential to maximize the potential of mHealth in health system strengthening. This was the 
rationale for a meeting of mHealth stakeholders that reviewed the work that is going on in the region and aimed at forging a united front for 
scaling up evidence-based mHealth interventions. The two-day workshop in May 2011 was held in Nairobi, Kenya and was jointly organized by the 
University of British Columbia (UBC) and the University of Nairobi Institute of Tropical and Infectious Diseases (UNITID), and funded by Global 
Health Research Initiative (GHRI) and Centre for Disease Control and Prevention (CDC) Kenya.  
  
High level adherence of 95% and above that can yield maximum viral suppression and reduce drug resistance to antiretroviral medications is still a 
challenge. Earlier studies with meta-analyses on adherence to anti-retroviral therapy (ART) in sub-Saharan Africa found that a pooled estimate of 
77% of patients in African settings achieved adequate adherence (95% of prescribed pills), compared with 55% of patients in North American 
settings [2]. However, adherence still poses a challenge in resource limited settings and there is still evidence of high rates of patient lost-to-follow 
up [3].  
  
Interventions using mobile phones to improve health outcomes such as adherence and retention in the ART programs are likely to be viable due to 
the wide access to mobile phones in most developing nations [4], the emerging evidence to support use of mobile phone interventions to improve 
health service delivery and the likelihood of these interventions leading to cost saving measures in the health system.  
  
  
Workshop report 
 
Aim of the workshop  
  
The aim of the workshop was to bring together various stakeholders who included researchers, academicians, information, communication and 
technology programmers, policy makers and members from the civil society to:1) review evidence based mHealth research for HIV care and 
treatment; 2) review mHealth applications developed to support adherence and retention in ART programs; 3) develop an mHealth evidence based 
framework for scale up and 4) identify gaps in evidence and the areas where more research is needed.  
  
On the first day of the workshop the mHealth concept, ART adherence and retention challenges and the role of mHealth, evidence for HIV-related 
mHealth interventions and mHealth interventions in other areas were presented and discussed. The second day of the workshop was dedicated to 
building partnerships and developing a framework for mHealth strengthening to support HIV care and treatment and other health conditions.  
  
Participants  
  
Fifty  participants  from  twenty  nine  organizations  in  Kenya,  Uganda,  Zambia,  Cameroon  and  Canada  attended  the  workshop.  They  included 
researchers, policy makers, health care implementers, information, communication and technology programmers, academicians and civil society 
representatives. Although the workshop initially targeted thirty participants, the high demand necessitated a request for additional funding to 
accommodate more participants.  
  
Day 1: mHealth Projects and lessons learned  
  
There were seventeen brief presentations during the first day, in which thirteen mHealth projects either in progress or completed, were discussed 
(Table 1 and Table 2). Some of the key issues and lessons learned from these presentations included:  
  
1) Adherence to antiretroviral medications continues to be a serious problem. Lester et al., 2010 mobile phone adherence intervention conducted 
in Kenya report that only 66% of patients on ART in the control arm with viral loads available achieved viral suppression (<400 copies/ml) after 
one year [1]. A study by Eleches et al., 2011 reported that only 40% of the patients achieved adherence levels above 90% over one year [5]. A 
study in Cameroon reported that 77% of patients on ART had poor adherence to clinical appointments [6]; 2) Evidence on interventions that use 
of mobile phones to support patients taking antiretroviral medications is emerging and these interventions can be used together with other proven 
interventions such as targeted adherence counseling to improve adherence; 3) Evidence suggests that weekly text message reminders are more 
effective in improving adherence compared to daily text messages [1,5]. A survey of patients attending a clinic in Nairobi, Kenya suggested 
patients are more interested in using cell phones to access health care providers than for medication reminders. Mobile phone initiatives may 
therefore be most effective when they are designed to link patients to health care providers through improved patient-provider communication that 
provides regular support to patients. This was also demonstrated by the WelTel Kenya1 trial;  4) Evidence based mHealth interventions to improve 
health outcomes need to be scaled up to ensure that the impact is felt by a large number of people in order to enable equitable access to health 
service provision throughout the country;  5) Proven HIV mHealth interventions may be immediately applicable to the management of other 
diseases  requiring  long  term  medication  such  as  tuberculosis,  diabetes,  asthma  and  cardiovascular  diseases;  6)  Development  of  mHealth 
applications  should  be  guided  by  health  system  needs  and  not  simply  driven  by  the  technology;  hence  the  importance  of  involving  all  the 
stakeholders such as health care providers, patients, government and other stakeholders in needs assessment before developing the applications; 
7) Engagement of patients is critical in developing mHealth interventions to ensure their values and perceptions are incorporated to achieve the 
right content (message) and intensity (message dose) of the text messages. Specific considerations that would need to be taken into account for 
reviews of the existing and upcoming evidence (Table 3) based on ongoing and completed studies [5,7,8] were also identified; 8) There is a 
potential for mHealth to improve health management information system (HMIS) related to HIV/AIDS and other health interventions in relation to Page number not for citation purposes  3 
data  accuracy,  completeness  and  timely  reporting,  leading  to  improvements  in  ARV  stock  management  in  health  centres,  better  access  to 
pharmaceuticals among HIV/AIDS patients, and ultimately higher rates of ARV adherence due to reduced health system failures.  
  
Day 2: Way forward/ recommendations  
  
The second day of the workshop was dedicated to developing a strategic action plan for strengthening of mHealth interventions to support care 
and treatment of HIV and other conditions. The participants formed three discussion groups that formulated the following recommendations:  
  
1) To develop and submit a harmonized regional evidence-based ART adherence and retention mHealth intervention. A regional stepped wedge 
study design [9,10] based on the evidence of the WelTel Kenya1 randomized controlled trial was proposed for regional implementation; 2) To work 
towards developing policy guidelines on mHealth  implementation  as well as ensure the existence  of a legal framework  to guide scale-up of 
mHealth interventions and uphold confidentiality and privacy of patient data. Participants suggested they would like to be involved in developing 
mHealth guidelines and since there is an existing e-Health committee in Kenya, one of the participants should be assigned to represent the 
mHealth pillar in this committee; 3) To work towards interoperability of mHealth systems to facilitate and foster collaboration in development of 
viable applications that are scalable, open source and can measure health outcomes;  4) To develop and communicate best practices in strategies 
and  approaches  for  private-public  partnerships  in  mHealth.  Participants  were  interested  in  understanding  how  others  have  created  strategic 
private-public partnerships and how these approaches can be used in mHealth; 5) To organize a follow up mHealth strategy meeting in three 
months time to concretize the recommendations developed during this meeting. The subsequent meetings should ensure adequate engagement of 
the government, donor agencies such as WHO, CDC UNAIDS, USAID, and IDRC and pharmaceutical companies.  
  
  
Conclusion 
 
The workshop generated greater interest for participation than expected which indicated the desire for a coordinated approach to implementing 
mHealth interventions in the region. It created a forum for participants to share and review mHealth interventions in the region. The evidence 
reviewed suggests that mobile phones can be used as monitoring and supporting tools to provide regular communication between patients and 
health  care  providers.  A  regional  evidence-based  cell  phone  intervention  to  support  patient  adherence  and  retention  in  ART  programs  was 
proposed. Participants acknowledged the importance of the workshop and agreed to hold a follow up meeting to reinforce the recommendations 
developed during this workshop.  
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Table 1: mHealth projects presented during the HIV mHealth synergy and strategy workshop in Nairobi, Kenya, 23-24 May 2011 
Project  Organization  Country  Activities 
WelTel Kenya1 (Final Results) 
 WelTel,  Universities  of 
Manitoba,  Nairobi  and  British 
Columbia 
Kenya 
A  randomized  controlled  clinical  trial  to  assess  use  of  text  messages  to  improve 
antiretroviral medications adherence and viral suppression. 
The study findings show that patients who received text messages had significantly 
improved self-reported adherence and viral suppression rates. 
 PMTCT  (Prevention  of  Mother  to 
Child Transmission) Study (Ongoing) 
 Universities  Manitoba  and 
Nairobi 
 Kenya 
A randomized controlled clinical trial to assess use of text messages to Improve ante 
natal clinic visits, increase usage of Nevirapine and decrease number of HIV infected 
infants born to HIV positive mothers. Study ongoing. 
 CAMPS 
(Cameroon  Mobile  Phone  SMS)  Trial 
(Ongoing) 
 Centre for the Development of 
Best  Practices  in  Health, 
Yaoundé 
 Cameroon 
A randomized controlled single blinded trial to test the efficacy of text messages and 
motivational  messages  in  improving  adherence  to  antiretroviral  medications.   Study 
ongoing. 
 Programmatic  evaluation  of  Cell 
phone  use  as  an  intervention  for 
antiretroviral resistance 
 KEMRI  (Kenya  Medical 
Research Institute) 
 Kenya 
A  pilot  study  to  determine  perceptions  regarding  use  of  cell  phone  to  support 
treatment adherence among people living with HIV. 
Patients  prefer  to  use  mobile  phones  to  facilitate  access  to  care  than  to  receive 
medication reminders. 
SMS Printer 
Ministry of Health, Zambia 
Zambia  
A  pilot  study  to  ascertain  whether  use  of  text  message  technology  can  reduce 
laboratory results turn-around time. Turn- around time was reduced to about 2.6weeks 
from baseline >6weeks 
Better  Health  Outcomes  through 
Health Mentoring (BHOMA)  Ministry of Health, Zambia  
Zambia  
A pilot study to evaluate use of text messages to prompt mentored lay workers to 
trace patients with health problems and refer them to the health facility. 
 HIV Track SMS Reminder System 
APHIA Plus Western Kenya 
Kenya  
A program that will use text messages as a reminder tool for clinic appointment and 
drug refill. 
 Mobile  phones  for  ART  service 
provision  AMREF  
Kenya  
Use of mobile phones by health care providers as a way to disseminate or access 
challenging information on HIV care and treatment. 
 IQSMS for PMTCT  Futures    Tanzania  Use of text messages to support PMTCT data reporting. 
Emit  (Evaluating  and  Monitoring 
Information System)   Cell life/KETAM 
South Africa  
Use mobile phones for data collection, monitoring and evaluation. 
 Cellphones4HIV   Cell life/KETAM   South Africa  Use of mobile phone technology in health related mass messaging. 
 Use of smart phones to monitor type 
2  diabetes  York University  
 Canada 
Use of smart phones to improve blood glucose control in type 2 diabetic patients. 
 Use  of  smart  phones  to  monitor 
heart failure  York University 
 Canada 
Use of smart phones to remotely monitor weight and blood pressure in heart failure 
patients. 
           Page number not for citation purposes  6 
  
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2: Other organizations making presentations  
Organization  Activities 
NEPHAK  Improving quality of life of people living with HIV through social mobilization, advocacy and 
capacity  building.  Key  areas  identified  that  can  be  strengthened  using  mHealth  technology 
include; receiving information on commodity and drug stock outs and relaying information on 
human rights violation. 
I-TECH  Strengthening  health  systems  through  development  and  implementation  of  standardized 
electronic medical records system, interoperability solutions and capacity building. I-TECH is 
also spearheading the development of standardized guidelines for EMR systems in Kenya. 
APHRC  Conducts research in four key areas: education, health, population dynamics and urbanization. 
The  evidence  acquired  is  then  used  for  policy  engagement.  See  a  place  for  mHealth 
interventions in the management of chronicity. 
Makerere University  Makerere University’s Clinical Trials Unit presented on evidence from Uganda on strategies to 
improve adherence and treatment outcomes. These strategies include: treatment assistants, 
group  adherence  counseling,  home  based  counseling,  nutritional  support  and  provision  of 
transportation cost. 
IDRC  Program areas include: enhancing equity and access to health care through evidence based 
research, funding and facilitating innovation, inter-disciplinary research and training programs, 
and building capacity to conduct HIV prevention trials. IDRC, through GHRI, is funding the trial 
on harnessing mobile phones for prevention of mother to child transmission in Kenya. Page number not for citation purposes  7 
Table 3: Considerations for authors reviewing the evidence on mobile phone text messages for improving adherence to ART 
Study  Pop-Eleche et al  Mbuagbaw et al*  Lester et al  Da Costa et al* 
Location  Kenya  Cameroon  Kenya  India 
Timing  Weekly/Daily  Weekly  Weekly  Weekly 
Length  Long/Short  Long  Short  NA 
Feedback  No  Yes  Yes  No 
Content  Motivational  Motivational  Support/Access  Picture 
Sending  Automated  Manual  Manual  Automated 
Measurement  MEMS  VAS/SR/PRD  SR/VL  VL (TTE)/SR 
Variety  No  Yes  No  No 
Duration  12 months  6 months  12 months  24 months 
Phone provided  Yes  No  No  Yes 
Sample size  431  198  538  600 
*Based on protocol ; SR : Self Report ; VL : Viral Load ; PRD : Pharmacy Refill Data ; TTE : Time-to-event ; MEMS : Medication 
Event Monitoring System 
  
  
 